סך נכסי הפעילות העסקית Collegium Pharma (COLL)

Collegium Pharmaceutical (COLL) specializes in developing analgesics, leveraging prescription volume and insurance coverage. This chart of total assets, valued at 1864.20, confirms the business's resilience. This stability is driven by raw material supply diversification and the maintenance of component inventories. A unique substance masking system creates high market barriers, protecting products from misuse and replication.

The metric is calculated inversely via return on assets (ROA), reflecting the dynamics of the balance sheet base depending on market value and operational efficiency. An analysis of the current level of gross assets allows for an assessment of the resilience of Collegium Pharmaceutical (COLL) resources to inflationary pressure and generic expansion, determining the company's ability to maintain infrastructure under strict regulation of the painkiller market.